Description Usage Format Source
This data is from the Mayo Clinic trial in primary biliary cirrhosis (PBC) of the liver conducted between 1974 and 1984. A total of 424 PBC patients, referred to Mayo Clinic during that ten-year interval, met eligibility criteria for the randomized placebo controlled trial of the drug D-penicillamine. The first 312 cases in the data set participated in the randomized trial and contain largely complete data. The additional 112 cases did not participate in the clinical trial, but consented to have basic measurements recorded and to be followed for survival. Six of those cases were lost to follow-up shortly after diagnosis, so the data here are on an additional 106 cases as well as the 312 randomized participants.
1 |
A data frame with 418 rows and 20 variables:
case number
number of days between registration and the earlier of death, transplantion, or study analysis in July, 1986
status at endpoint, 0/1/2 for censored, transplant, dead
1/2/NA for D-penicillmain, placebo, not randomised
in years
m/f
presence of ascites
presence of hepatomegaly or enlarged liver
blood vessel malformations in the skin
0 no edema, 0.5 untreated or successfully treated, 1 edema despite diuretic therapy
serum bilirunbin (mg/dl)
serum cholesterol (mg/dl)
serum albumin (g/dl)
urine copper (ug/day)
alkaline phosphotase (U/liter)
aspartate aminotransferase, once called SGOT (U/ml)
triglycerides (mg/dl)
platelet count
standardised blood clotting time
histologic stage of disease (needs biopsy)
TR Fleming and DP Harrington (1991), Counting Processes and Survival Analysis. Wiley, New York. ISBN: 0-471-52218-X.
https://stat.ethz.ch/R-manual/R-devel/library/survival/html/pbc.html
http://www-eio.upc.edu/~pau/cms/rdata/csv/survival/pbc.csv
Data downloaded on 2018 March 28
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.